Philip Newland-Jones
banner
pnewland-jones.bsky.social
Philip Newland-Jones
@pnewland-jones.bsky.social
Consultant Pharmacist in Diabetes & Endocrinology and Clinical Director of D&E at University Hospitals Southampton - Other roles on LinkedIn.

https://uk.linkedin.com/pub/philip-newland-jones/61/623/464
Please share -On Earth Day, a gentle reminder of the options to go a little greener for those on insulin/weight management disposable pen devices.

mysanofiinsulin.co.uk/repen/

pen-cycle.co.uk -Novo

Other options
Cartridges and reusable pen

Hopefully @elilillyandcompany.bsky.social join the club?
mysanofiinsulin.co.uk
April 22, 2025 at 2:01 PM
Reposted by Philip Newland-Jones
Today's new #TalkingMeds podcast sees Jonathan Underhill and special guest Philip Newland-Jones cover the major talking points around obesity management.

Listen to the podcast here: www.prescqipp.info/our-resource...

@jonathanunderhill.pharmsky.app @pnewland-jones.bsky.social
April 18, 2025 at 10:56 AM
Reposted by Philip Newland-Jones
An excellent follow on podcast about the challenges of Obesity medicines by the 5 th Apothecary @jonathanunderhill.pharmsky.app with consultant pharmacist @pnewland-jones.bsky.social 👏👏 podcasts.apple.com/gb/podcast/t...
Talking Meds - A PrescQIPP podcast
Medicine Podcast · Updated fortnightly ·  Engaging conversations about medicines-related dilemmas.Talking Meds is hosted by Jonathan Underhill who, every two weeks, will chat to a fantastic guest abou...
podcasts.apple.com
April 19, 2025 at 10:09 AM
Reposted by Philip Newland-Jones
An excellent follow on podcast about the challenges of Obesity medicines by the 5 th Apothecary @jonathanunderhill.pharmsky.app with consultant pharmacist @pnewland-jones.bsky.social 👏👏 podcasts.apple.com/gb/podcast/t...
April 19, 2025 at 10:10 AM
Reposted by Philip Newland-Jones
Up front & free to read in our April issue #editorspicks: Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial link.springer.com/article/10.1...
Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial - Diabetologia
Aims/hypothesis COMBINE 2 assessed the efficacy and safety of once-weekly IcoSema (a combination therapy of basal insulin icodec and semaglutide) vs once-weekly semaglutide (a glucagon-like peptide-1 ...
link.springer.com
April 9, 2025 at 11:31 AM
First Job for this morning-
Reporting an online pharmacy for completely inappropriate prescribing of weight loss medication, leading to hospitalisation. (Individual’s BMI 21)

Please report this every time you come across it

Reminder of updated guidance assets.pharmacyregulation.org/files/2025-0...
April 3, 2025 at 7:03 AM
4th March was world obesity day. I’m pleased that obesity, as a disease, is beginning to get the attention it needs amongst healthcare professionals.

Pharmacists are well placed to support, and I look forward to educating + empowering at this i2i network event. link in reply below👇 1/2
March 5, 2025 at 8:09 AM